100 job cuts as Roche switches genome sequencing focus
This article was originally published in Clinica
Executive Summary
Roche is phasing out its 454 Life Sciences genome sequencing systems by mid-2016, as it focuses on a recent deal with another sequencing specialist, Pacific Biosciences – giving it access to new cutting-edge sequencing technology. The move will involve shutting Roche’s Branford site and around 100 job cuts, a spokesperson told Clinica.